Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Correction: TRPM7 promotes the epithelial– mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling

The Original Article was published on 28 February 2019

Correction: J Exp Clin Cancer Res 38, 106 (2019)

https://doi.org/10.1186/s13046-019-1061-y


Following publication of the original article [1], the authors identified minor errors in image typesetting in Fig. 5, specifically the invasion experiment detailed in Fig. 5C

The corrections do not have any effect on the results or conclusions of the paper. The correct figure is presented below:

Incorrect Fig. 5

Fig. 5
figure 1

Calcium is crucial for the PI3K/AKT signaling-mediated migration and invasion of ovarian cancer cells. (a) Flow cytometry analysis of [Ca2 +]i. SKOV3 and OVCAR3 cells were treated with (b), or without (a), 20 μg/ml BAPTA-AM for 12 h and labeled with Fluo-8 AM, followed by exposed to calcium-containing or calcium-free HANK’s solution, respectively. The cells did not receive BAPTA-AM treatment and exposed to calciumcontaining HANK’s solution (c); the control cells as described above (d). (b) Fluorescent microscopy. SKOV3 and OVCAR3 cells were treated with, or without, 20 μg/ml BAPTA-AM for 12 h and labeled with Fluo-8 AM, followed by examining under a fluorescent microscope. (c-f) Blocking the calcium signaling is crucial for the PI3K/AKT signaling-mediated migration and invasion of ovarian cancer cells. SKOV3 and OVCAR3 cells were treated with vehicle or BAPTA-AM and/or 10 μg/ml LY294002 or 100 ng/ml IGF for 48 h. The migration, invasion (c, e) and wound healing (d, f) of cells were determined. Data are representative images or expressed as the mean ± SD of each group of cells from three separate experiments. *p < 0.05, **p < 0.01, ***p < 0.001 vs the controls

Correct Fig. 5

Fig. 5
figure 2

Calcium is crucial for the PI3K/AKT signaling-mediated migration and invasion of ovarian cancer cells. (a) Flow cytometry analysis of [Ca2 +]i. SKOV3 and OVCAR3 cells were treated with (b), or without (a), 20 μg/ml BAPTA-AM for 12 h and labeled with Fluo-8 AM, followed by exposed to calcium-containing or calcium-free HANK’s solution, respectively. The cells did not receive BAPTA-AM treatment and exposed to calciumcontaining HANK’s solution (c); the control cells as described above (d). (b) Fluorescent microscopy. SKOV3 and OVCAR3 cells were treated with, or without, 20 μg/ml BAPTA-AM for 12 h and labeled with Fluo-8 AM, followed by examining under a fluorescent microscope. (c-f) Blocking the calcium signaling is crucial for the PI3K/AKT signaling-mediated migration and invasion of ovarian cancer cells. SKOV3 and OVCAR3 cells were treated with vehicle or BAPTA-AM and/or 10 μg/ml LY294002 or 100 ng/ml IGF for 48 h. The migration, invasion (c, e) and wound healing (d, f) of cells were determined. Data are representative images or expressed as the mean ± SD of each group of cells from three separate experiments. *p < 0.05, **p < 0.01, ***p < 0.001 vs the controls

Reference

  1. Liu L, Wu N, Wang Y, et al. TRPM7 promotes the epithelial–mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling. J Exp Clin Cancer Res. 2019;38:106. https://doi.org/10.1186/s13046-019-1061-y.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Qianjin Liao or Jing Wang.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, L., Wu, N., Wang, Y. et al. Correction: TRPM7 promotes the epithelial– mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling. J Exp Clin Cancer Res 43, 291 (2024). https://doi.org/10.1186/s13046-024-03212-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-024-03212-7